Celyad Oncology
Can this company survive a downturn?
How efficiently does it turn assets into profit?
Is the business becoming more valuable over time?
1.1. Financial Health of Celyad Oncology (5 min.)
π€ Analyze $CYAD using your own AI
Download Penkeβs AI-structured dataset for Celyad Oncology.
Ask your own questions, run scenarios, and test assumptions in the AI you already use.
Your edge in this era:
π₯Έ Penkeβs data + π€ AI + π§ YOUR judgment.
You can use the AI prompts per pain point I prepared to guide your analysis.
Want to see how it works first? Start with a real example:
π₯ Download example dataset ($NVDA)* I continuously improve the AI structure.
If something feels unclear or incomplete, email me or message me on Discord.
β Iβll fix it. π₯Έ Penke
Key Takeaways
What matters most right now.
β Revenue growth
Revenue grew 82.4% last quarter to $0.0B. Compared to the 5-year average revenue level of $0.0B, the business continues to expand in scale.
β Profitability
Net profit margin is -3131.2%, close to its 5-year average of -118497.8%. This indicates profitability is broadly in line with the companyβs long-term performance.
β Cash generation
Free cash flow of $0.0B equals a -3053.8% margin, broadly in line with its 5-year average of -191713%, indicating stable cash generation.
β Financial resilience
The company has a current ratio of 2.29, compared to a 5-year average of 2.28. This shows how well it can cover short-term obligations if conditions worsen.
β Debt levels
Debt relative to equity is 0, compared to a 5-year average of 0. This shows whether leverage is increasing or staying disciplined.
β οΈ Capital efficiency
Return on equity is -1139.7%, compared to a 5-year average of -467.6%. This shows how effectively management turns shareholder capital into profit.
Why this matters
The facts behind the takeaways.
β How much profit the business keeps
The company keeps -3149.5% profit from its sales. Over the past 5 years, this was about -117060.2%.
β How much cash the business generates
About -3053.8% of sales turns into real cash. Historically, this was closer to -191713%.
β Ability to pay short-term bills
The companyβs short-term financial buffer is 2.29, compared to 2.28 historically.
β Debt pressure
Debt levels are 0 today, compared to 0 over the last 5 years.
What to watch next
Focus points for the next quarters.
β Next earnings
Watch whether revenue growth translates into sustained margin improvement next quarter.
Balance Sheet
Showing financial position from 2020-01-01 to 2025-01-01.
| 2025-01-01 | 2024-01-01 | 2023-01-01 | 2022-01-01 | 2021-01-01 | 2020-01-01 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total | π Member | 16,282 | 19,716 | 79,943 | 66,084 | π Member |
| Current | ||||||
| Total | π Member | 11,121 | 12,445 | 34,292 | 19,705 | π Member |
| Cash | π Member | 7,004 | 12,445 | 30,018 | 17,234 | π Member |
| Cash Equivalents | π Member | 0 | 0 | 0 | 0 | π Member |
| Short Term Investments | π Member | 0 | 0 | 0 | 0 | π Member |
| Accounts Receivable | π Member | 457 | 1,118 | 668 | 615 | π Member |
| Inventory | ||||||
| Total | π Member | 0 | 0 | 0 | 0 | π Member |
| Inventory Finished Goods | π Member | 0 | 0 | 0 | 0 | π Member |
| Inventory Raw Materials | π Member | 0 | 0 | 0 | 0 | π Member |
| Inventory Parts | π Member | 0 | 0 | 0 | 0 | π Member |
| Inventory WIP | π Member | 0 | 0 | 0 | 0 | π Member |
| Prepaid Expenses | π Member | 0 | 0 | 0 | 0 | π Member |
| Noncurrent | ||||||
| Property Plant And Equipment | π Member | 1,830 | 309 | 3,248 | 4,119 | π Member |
| Intangible Assets | π Member | 0 | 0 | 0 | 0 | π Member |
| Goodwill | π Member | 0 | 0 | 0 | 0 | π Member |
| Right Of Use Assets | π Member | 0 | 0 | 0 | 0 | π Member |
| Long Term Investments | π Member | 0 | 0 | 0 | 0 | π Member |
| Deferred Tax Assets | π Member | 0 | 0 | 0 | 0 | π Member |
| Other Assets | π Member | 137 | 264 | 262 | 293 | π Member |
| Total | π Member | 1,967 | 573 | 3,510 | 4,412 | π Member |
| Liabilities | ||||||
| Total | π Member | 0 | 0 | 0 | 0 | π Member |
| Current | ||||||
| Total | π Member | 2,932 | 10,426 | 13,827 | 11,834 | π Member |
| Accounts Payable | π Member | 0 | 0 | 0 | 0 | π Member |
| Accrued Liabilities | π Member | 936 | 5,100 | 5,952 | 5,614 | π Member |
| Short Term Debt | π Member | 0 | 0 | 0 | 37 | π Member |
| Deferred Revenue | π Member | 0 | 0 | 0 | 0 | π Member |
| Lease Liabilities | π Member | 0 | 0 | 0 | 0 | π Member |
| Other Current Liabilities | π Member | 0 | 0 | 0 | 0 | π Member |
| Noncurrent | ||||||
| Long Term Debt | π Member | 0 | 0 | 0 | 0 | π Member |
| Lease Liabilities | π Member | 0 | 0 | 0 | 0 | π Member |
| Operating Lease Liabilities | π Member | 0 | 0 | 0 | 0 | π Member |
| Deferred Revenue | π Member | 0 | 0 | 0 | 0 | π Member |
| Deferred Tax Liabilities | π Member | 0 | 0 | 0 | 0 | π Member |
| Total | π Member | 7,046 | 4,973 | 22,477 | 23,256 | π Member |
| Equity | ||||||
| Total | π Member | 6,304 | 4,317 | 43,639 | 30,994 | π Member |
| Common Stock | π Member | 32,949 | 78,585 | 78,585 | 48,513 | π Member |
| Preferred Stock | π Member | 0 | 0 | 0 | 0 | π Member |
| Additional Paid In Capital | π Member | 0 | 6,317 | 6,317 | 43,349 | π Member |
| Retained Earnings | π Member | -358,372 | -349,947 | -308,997 | -283,039 | π Member |
| Accumulated Other Comprehensive Income | π Member | 35,734 | 34,800 | 33,172 | 30,958 | π Member |
| Treasury Stock | π Member | 0 | 0 | 0 | 0 | π Member |
| Minority Interest | π Member | 0 | 0 | 0 | 0 | π Member |
| Temporary Equity | π Member | 0 | 0 | 0 | 0 | π Member |
Income Statement
Performance overview from 2020-01-01 to 2025-01-01.
| 2025-01-01 | 2024-01-01 | 2023-01-01 | 2022-01-01 | 2021-01-01 | 2020-01-01 | |
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Total | π Member | 102 | 0 | 0 | 5 | π Member |
| Segments | ||||||
| Segment1 | π Member | 0 | 0 | 0 | 0 | π Member |
| Segment2 | π Member | 0 | 0 | 0 | 0 | π Member |
| Segment3 | π Member | 0 | 0 | 0 | 0 | π Member |
| Cost Of Revenue | ||||||
| Total | π Member | 69 | 0 | 0 | 0 | π Member |
| Gross Profit | π Member | 33 | 0 | 0 | 5 | π Member |
| Operating Expenses | ||||||
| Total | π Member | 4,602 | 18,928 | 20,773 | 21,522 | π Member |
| Research And Development | π Member | 4,602 | 18,928 | 20,773 | 21,522 | π Member |
| Selling General And Administrative | π Member | 0 | 0 | 0 | 0 | π Member |
| Stock Based Compensation | π Member | 0 | 0 | 0 | 0 | π Member |
| Allocated Stock Based Compensation | π Member | 0 | 0 | 0 | 0 | π Member |
| Impairment Charges | π Member | 0 | 0 | 0 | 0 | π Member |
| Restructuring Charges | π Member | 0 | 0 | 0 | 0 | π Member |
| Other Operating Expenses | π Member | 0 | 0 | 0 | 0 | π Member |
| Operating Income | π Member | -8,457 | -40,857 | -26,391 | -16,987 | π Member |
| Non Operating | ||||||
| Interest Income | π Member | 30 | 185 | 144 | 217 | π Member |
| Interest Expense | π Member | 84 | 198 | 255 | 434 | π Member |
| Gain On Asset Sales | π Member | 0 | 0 | 0 | 0 | π Member |
| Other Non Operating Income | π Member | 0 | 0 | 0 | 0 | π Member |
| Income Before Tax | π Member | -8,511 | -40,870 | -26,502 | -17,204 | π Member |
| Income Tax | π Member | -63 | 65 | 10 | 0 | π Member |
| Net Income | π Member | -8,448 | -40,935 | -26,512 | -17,204 | π Member |
Cash Flow Statement
Operational cash dynamics from 2020-01-01 to 2025-01-01.
| 2025-01-01 | 2024-01-01 | 2023-01-01 | 2022-01-01 | 2021-01-01 | 2020-01-01 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | π Member | -8,448 | -40,935 | -26,512 | -17,204 | π Member |
| Adjustments | ||||||
| Depreciation And Amortization | π Member | 0 | 0 | 0 | 0 | π Member |
| Stock Based Compensation | π Member | 0 | 0 | 0 | 0 | π Member |
| Impairments | π Member | 0 | 0 | 0 | 0 | π Member |
| Deferred Taxes | π Member | 0 | 0 | 0 | 0 | π Member |
| Gain On Asset Sales | π Member | 0 | 0 | 0 | 0 | π Member |
| Change In Working Capital | π Member | 0 | 0 | 0 | 0 | π Member |
| Cash From Operations | π Member | -15,202 | -28,010 | -26,643 | -27,665 | π Member |
| Investing Activities | ||||||
| Cash From Investing | π Member | 407 | 7,202 | -126 | 157 | π Member |
| Capital Expenditures | π Member | 899 | 123 | 331 | 150 | π Member |
| Acquisitions | π Member | 0 | 0 | 0 | 0 | π Member |
| Purchase Of Investments | π Member | 0 | 0 | 0 | 0 | π Member |
| Sale Of Investments | π Member | 0 | 0 | 0 | 0 | π Member |
| Financing Activities | ||||||
| Cash From Financing | π Member | 9,355 | 3,241 | 39,521 | 5,396 | π Member |
| Debt Issued | π Member | 0 | 0 | 0 | 0 | π Member |
| Debt Repaid | π Member | 0 | 0 | 0 | 0 | π Member |
| Convertible Debt Repaid | π Member | 0 | 0 | 0 | 0 | π Member |
| Debt Issuance Costs | π Member | 0 | 0 | 0 | 0 | π Member |
| Dividends Paid | π Member | 0 | 0 | 0 | 0 | π Member |
| Share Repurchases | π Member | 0 | 0 | 0 | 0 | π Member |
| Share Issuance | π Member | 0 | 0 | 0 | 0 | π Member |
| Lease Principal Payments | π Member | 0 | 0 | 0 | 0 | π Member |
| Minority Interest Distributions | π Member | 0 | 0 | 0 | 0 | π Member |
| Other | ||||||
| Taxes Paid | π Member | 0 | 0 | 0 | 0 | π Member |
| Interest Paid | π Member | 0 | 0 | 0 | 0 | π Member |
| Effect Of Exchange Rate On Cash | π Member | 0 | 0 | 0 | 0 | π Member |
| Summary | ||||||
| Net Change In Cash | π Member | -7,004 | -12,445 | -30,018 | -17,234 | π Member |
| Beginning Cash | π Member | 7,004 | 12,445 | 30,018 | 17,234 | π Member |
| Ending Cash | - | 0 | 0 | 0 | 0 | π Member |